Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3347-3354

  Xu, Li S ^a   Sokalski, Kristen M ^a   Hotke, Kathryn ^a   Christie, Darah A ^a   Zarnett, Oren ^a   Piskorz, Jan ^a   Thillainadesan, Gobi ^b,c   Torchia, Joseph ^b,c   DeKoter, Rodney P ^a,d  

^a WESTERN UNIVERSITY   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LINKER PROTEIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; ONCOPROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SPI B; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; BINDING SITE; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL LINEAGE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NIH 3T3 CELLS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, ANTIGEN, B-CELL; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84866557333     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201267     Document Type: Article

References (59)

1. Pui, C. H., L. L. Robison, and A. T. Look. 2008. Acute lymphoblastic leukaemia. Lancet 371: 1030-1043.
2. Cobaleda, C., and I. Sánchez-García. 2009. B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays 31: 600-609.
3. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
4. Iwasaki, H., C. Somoza, H. Shigematsu, E. A. Duprez, J. Iwasaki-Arai, S. Mizuno, Y. Arinobu, K. Geary, P. Zhang, T. Dayaram, et al. 2005. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106: 1590-1600. (Pubitemid 41208570)
5. Mueller, B. U., T. Pabst, M. Osato, N. Asou, L. M. Johansen, M. D. Minden, G. Behre, W. Hiddemann, Y. Ito, and D. G. Tenen. 2002. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 100: 998-1007. (Pubitemid 34832629)
6. Link, D. C., G. Kunter, Y. Kasai, Y. Zhao, T. Miner, M. D. McLellan, R. E. Ries, D. Kapur, R. Nagarajan, D. C. Dale, et al. 2007. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 110: 1648-1655. (Pubitemid 47443983)
7. Mullighan, C. G., J. Zhang, L. H. Kasper, S. Lerach, D. Payne-Turner, L. A. Phillips, S. L. Heatley, L. Holmfeldt, J. R. Collins-Underwood, J. Ma, et al. 2011. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471: 235-239.
8. Rosenbauer, F., K. Wagner, J. L. Kutok, H. Iwasaki, M. M. Le Beau, Y. Okuno, K. Akashi, S. Fiering, and D. G. Tenen. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36: 624-630. (Pubitemid 38715991)
9. Walter, M. J., J. S. Park, R. E. Ries, S. K. Lau, M. McLellan, S. Jaeger, R. K.Wilson, E. R. Mardis, and T. J. Ley. 2005. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Proc. Natl. Acad. Sci. USA 102: 12513-12518. (Pubitemid 41266390)
10. Nishii, K., K. Kita, H. Miwa, M. Shikami, M. Taniguchi, E. Usui, N. Katayama, and H. Shiku. 2000. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype. Int. J. Hematol. 71: 372-378.
11. Jundt, F., K. Kley, I. Anagnostopoulos, K. Schulze Pröbsting, A. Greiner, S. Mathas, C. Scheidereit, T. Wirth, H. Stein, and B. Dörken. 2002. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 99: 3060-3062. (Pubitemid 34525400)
12. Ray, D., R. Bosselut, J. Ghysdael, M. G. Mattei, A. Tavitian, and F. Moreau-Gachelin. 1992. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol. Cell. Biol. 12: 4297-4304.
13. Wei, G. H., G. Badis, M. F. Berger, T. Kivioja, K. Palin, M. Enge, M. Bonke, A. Jolma, M. Varjosalo, A. R. Gehrke, et al. 2010. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 29: 2147-2160.
14. Fuka, G., M. Kauer, R. Kofler, O. A. Haas, and R. Panzer-Grümayer. 2011. The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression. PLoS ONE 6: e26348.
15. Sokalski, K. M., S. K. Li, I. Welch, H. A. Cadieux-Pitre, M. R. Gruca, and R. P. DeKoter. 2011. Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia. Blood 118: 2801-2808.
16. Minegishi, Y., J. Rohrer, E. Coustan-Smith, H. M. Lederman, R. Pappu, D. Campana, A. C. Chan, and M. E. Conley. 1999. An essential role for BLNK in human B cell development. Science 286: 1954-1957. (Pubitemid 129515903)
17. Pappu, R., A. M. Cheng, B. Li, Q. Gong, C. Chiu, N. Griffin, M. White, B. P. Sleckman, and A. C. Chan. 1999. Requirement for B cell linker protein (BLNK) in B cell development. Science 286: 1949-1954. (Pubitemid 129515902)
18. Jumaa, H., B. Wollscheid, M. Mitterer, J. Wienands, M. Reth, and P. J. Nielsen. 1999. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11: 547-554.
19. Wienands, J., J. Schweikert, B. Wollscheid, H. Jumaa, P. J. Nielsen, and M. Reth. 1998. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 188: 791-795. (Pubitemid 28387943)
20. Fu, C., C. W. Turck, T. Kurosaki, and A. C. Chan. 1998. BLNK: a central linker protein in B cell activation. Immunity 9: 93-103. (Pubitemid 28361298)
21. Mullighan, C. G., S. Goorha, I. Radtke, C. B. Miller, E. Coustan-Smith, J. D. Dalton, K. Girtman, S. Mathew, J. Ma, S. B. Pounds, et al. 2007. Genomewide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764. (Pubitemid 46582031)
22. Zhang, J., C. G. Mullighan, R. C. Harvey, G. Wu, X. Chen, M. Edmonson, K. H. Buetow, W. L. Carroll, I. M. Chen, M. Devidas, et al. 2011. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118: 3080-3087.
23. Jumaa, H., L. Bossaller, K. Portugal, B. Storch, M. Lotz, A. Flemming, M. Schrappe, V. Postila, P. Riikonen, J. Pelkonen, et al. 2003. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 423: 452-456. (Pubitemid 36626998)
24. Flemming, A., T. Brummer, M. Reth, and H. Jumaa. 2003. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat. Immunol. 4: 38-43. (Pubitemid 36104706)
25. Winkler, T. H., F. Melchers, and A. G. Rolink. 1995. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood 85: 2045-2051.
26. Christie, D. A., C. D. Lemke, I. M. Elias, L. A. Chau, M. G. Kirchhof, B. Li, E. H. Ball, S. D. Dunn, G. M. Hatch, and J. Madrenas. 2011. Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function. Mol. Cell. Biol. 31: 3845-3856.
27. Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942. (Pubitemid 40916416)
28. DeKoter, R. P., H. J. Lee, and H. Singh. 2002. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16: 297-309. (Pubitemid 34211968)
29. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066. (Pubitemid 30398356)
30. Godbey, W. T., K. K. Wu, and A. G. Mikos. 1999. Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60: 149-160. (Pubitemid 29335941)
31. DeKoter, R. P., M. Geadah, S. Khoosal, L. S. Xu, G. Thillainadesan, J. Torchia, S. S. Chin, and L. A. Garrett-Sinha. 2010. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol. 185: 7374-7384.
32. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
33. Cooper, M. D., D. Mulvaney, A. Coutinho, and P. A. Cazenave. 1986. A novel cell surface molecule on early B-lineage cells. Nature 321: 616-618. (Pubitemid 16042214)
34. McKearn, J. P., C. Baum, and J. M. Davie. 1984. Cell surface antigens expressed by subsets of pre-B cells and B cells. J. Immunol. 132: 332-339. (Pubitemid 14212150)
35. Ochiai, K., M. Maienschein-Cline, M. Mandal, J. R. Triggs, E. Bertolino, R. Sciammas, A. R. Dinner, M. R. Clark, and H. Singh. 2012. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat. Immunol. 13: 300-307.
36. Medina, K. L., J. M. Pongubala, K. L. Reddy, D. W. Lancki, R. Dekoter, M. Kieslinger, R. Grosschedl, and H. Singh. 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7: 607-617. (Pubitemid 39341845)
37. Rolink, A. G., E. ten Boekel, T. Yamagami, R. Ceredig, J. Andersson, and F. Melchers. 1999. B cell development in the mouse from early progenitors to mature B cells. Immunol. Lett. 68: 89-93. (Pubitemid 29265657)
38. Schebesta, M., P. L. Pfeffer, and M. Busslinger. 2002. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17: 473-485. (Pubitemid 35223536)
39. Stehling-Sun, S., J. Dade, S. L. Nutt, R. P. DeKoter, and F. D. Camargo. 2009. Regulation of lymphoid versus myeloid fate 'choice' by Mef2c. Nat. Immunol. 10: 289-296.
40. Nelsen, B., G. Tian, B. Erman, J. Gregoire, R. Maki, B. Graves, and R. Sen. 1993. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. Science 261: 82-86. (Pubitemid 23265381)
41. Heinz, S., C. Benner, N. Spann, E. Bertolino, Y. C. Lin, P. Laslo, J. X. Cheng, C. Murre, H. Singh, and C. K. Glass. 2010. Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38: 576-589.
42. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331: 277-280. (Pubitemid 18040597)
43. Rosenbauer, F., B. M. Owens, L. Yu, J. R. Tumang, U. Steidl, J. L. Kutok, L. K. Clayton, K. Wagner, M. Scheller, H. Iwasaki, et al. 2006. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38: 27-37. (Pubitemid 43011879)
44. Metcalf, D., A. Dakic, S. Mifsud, L. Di Rago, L. Wu, and S. Nutt. 2006. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc. Natl. Acad. Sci. USA 103: 1486-1491. (Pubitemid 43191192)
45. Lenz, G., G. W. Wright, N. C. Emre, H. Kohlhammer, S. S. Dave, R. E. Davis, S. Carty, L. T. Lam, A. L. Shaffer, W. Xiao, et al. 2008. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. USA 105: 13520-13525.
46. Nakayama, J., M. Yamamoto, K. Hayashi, H. Satoh, K. Bundo, M. Kubo, R. Goitsuka, M. A. Farrar, and D. Kitamura. 2009. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood 113: 1483-1492.
47. Herzog, S., E. Hug, S. Meixlsperger, J. H. Paik, R. A. DePinho, M. Reth, and H. Jumaa. 2008. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat. Immunol. 9: 623-631. (Pubitemid 351712633)
48. Touw, I., K. Pouwels, T. van Agthoven, R. van Gurp, L. Budel, H. Hoogerbrugge, R. Delwel, R. Goodwin, A. Namen, and B. Löwenberg. 1990. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 75: 2097-2101. (Pubitemid 20181157)
49. Shochat, C., N. Tal, O. R. Bandapalli, C. Palmi, I. Ganmore, G. te Kronnie, G. Cario, G. Cazzaniga, A. E. Kulozik, M. Stanulla, et al. 2011. Gain-of-function mutations in interleukin-7 receptor-a (IL7R) in childhood acute lymphoblastic leukemias. J. Exp. Med. 208: 901-908.
50. Rich, B. E., J. Campos-Torres, R. I. Tepper, R. W. Moreadith, and P. Leder. 1993. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177: 305-316. (Pubitemid 23117080)
51. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, H. Yoshida, and S. Nishikawa. 1993. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 90: 9125-9129. (Pubitemid 23306464)
52. Garrett-Sinha, L. A., G. H. Su, S. Rao, S. Kabak, Z. Hao, M. R. Clark, and M. C. Simon. 1999. PU.1 and Spi-B are required for normal B cell receptormediated signal transduction. Immunity 10: 399-408. (Pubitemid 29205476)
53. Garrett-Sinha, L. A., P. Hou, D. Wang, B. Grabiner, E. Araujo, S. Rao, T. J. Yun, E. A. Clark, M. C. Simon, and M. R. Clark. 2005. Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. Gene 353: 134-146. (Pubitemid 40805367)
54. Müller, S., A. Maas, T. C. Islam, P. Sideras, G. Suske, S. Philipsen, K. G. Xanthopoulos, R. W. Hendriks, and C. I. Smith. 1999. Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1. Biochem. Biophys. Res. Commun. 259: 364-369. (Pubitemid 29281238)
55. Ta, V. B., A. B. de Haan, M. J. de Bruijn, G. M. Dingjan, and R. W. Hendriks. 2011. Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity. Leukemia 25: 48-56.
56. Huang, G., P. Zhang, H. Hirai, S. Elf, X. Yan, Z. Chen, S. Koschmieder, Y. Okuno, T. Dayaram, J. D. Growney, et al. 2008. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat. Genet. 40: 51-60.
57. Vangala, R. K., M. S. Heiss-Neumann, J. S. Rangatia, S. M. Singh, C. Schoch, D. G. Tenen, W. Hiddemann, and G. Behre. 2003. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 101: 270-277. (Pubitemid 36025918)
58. Wang, L., A. Gural, X. J. Sun, X. Zhao, F. Perna, G. Huang, M. A. Hatlen, L. Vu, F. Liu, H. Xu, et al. 2011. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 333: 765-769.
59. Kamino, H., M. Futamura, Y. Nakamura, N. Kitamura, K. Kabu, and H. Arakawa. 2008. B-cell linker protein prevents aneuploidy by inhibiting cytokinesis. Cancer Sci. 99: 2444-2454.